Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anna Tsapara

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
Cancer Biology & Therapy|March 17, 2020
The histone demethylase KDM2B activates FAK and PI3K that control tumor cell motilityNefeli Zacharopoulou, Galatea Kallergi, Saad Alkahtani, et al.
Cell Death Discovery|March 28, 2026
IOA-244, a novel p110δ PI3K inhibitor, blocks breast tumour progression on either mono- or combined-therapyEvangelia Goulielmaki, Anna Tsapara, Lydia Xenou, et al.
Oncotarget|April 15, 2015
Chorein addiction in VPS13A overexpressing rhabdomyosarcoma cellsSabina Honisch, Willi Yu, Guilai Liu, et al.
Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology|May 18, 2018
The Epigenetic Factor KDM2B Regulates EMT and Small GTPases in Colon Tumor CellsNefeli Zacharopoulou, Anna Tsapara, Galatea Kallergi, et al.
Oncotarget|March 31, 2016
Functional characterization and anti-cancer action of the clinical phase II cardiac Na+/K+ ATPase inhibitor istaroxime: in vitro and in vivo properties and cross talk with the membrane androgen receptorKonstantinos Alevizopoulos, Konstantinos Dimas, Natalia Papadopoulou, et al.
Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology|August 29, 2015
Chorein Sensitive Arrangement of Cytoskeletal ArchitectureSabina Honisch, Shuchen Gu, Jennifer Müller Vom Hagen, et al.
Communications Biology|January 5, 2024
A combined opposite targeting of p110δ PI3K and RhoA abrogates skin cancerNiki Tzenaki, Lydia Xenou, Evangelia Goulielmaki, et al.
Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology|July 14, 2017
Istaroxime Inhibits Motility and Down-Regulates Orai1 Expression, SOCE and FAK Phosphorylation in Prostate Cancer CellsMatias Julian Stagno, Nefeli Zacharopoulou, Jonas Bochem, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Cancer Biology & Therapy|March 17, 2020
The histone demethylase KDM2B activates FAK and PI3K that control tumor cell motilityNefeli Zacharopoulou, Galatea Kallergi, Saad Alkahtani, et al.
Cell Death Discovery|March 28, 2026
IOA-244, a novel p110δ PI3K inhibitor, blocks breast tumour progression on either mono- or combined-therapyEvangelia Goulielmaki, Anna Tsapara, Lydia Xenou, et al.
Oncotarget|April 15, 2015
Chorein addiction in VPS13A overexpressing rhabdomyosarcoma cellsSabina Honisch, Willi Yu, Guilai Liu, et al.
Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology|May 18, 2018
The Epigenetic Factor KDM2B Regulates EMT and Small GTPases in Colon Tumor CellsNefeli Zacharopoulou, Anna Tsapara, Galatea Kallergi, et al.
Oncotarget|March 31, 2016
Functional characterization and anti-cancer action of the clinical phase II cardiac Na+/K+ ATPase inhibitor istaroxime: in vitro and in vivo properties and cross talk with the membrane androgen receptorKonstantinos Alevizopoulos, Konstantinos Dimas, Natalia Papadopoulou, et al.
Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology|August 29, 2015
Chorein Sensitive Arrangement of Cytoskeletal ArchitectureSabina Honisch, Shuchen Gu, Jennifer Müller Vom Hagen, et al.
Communications Biology|January 5, 2024
A combined opposite targeting of p110δ PI3K and RhoA abrogates skin cancerNiki Tzenaki, Lydia Xenou, Evangelia Goulielmaki, et al.
Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology|July 14, 2017
Istaroxime Inhibits Motility and Down-Regulates Orai1 Expression, SOCE and FAK Phosphorylation in Prostate Cancer CellsMatias Julian Stagno, Nefeli Zacharopoulou, Jonas Bochem, et al.
Pageof 2